PI Industries Ltd (PI) has entered into a strategic collaboration with the Centre for Cellular And Molecular Platforms (C-CAMP), an initiative under the Department of Biotechnology, Ministry of Science and Technology, Government of India. This partnership aims to advance sustainable, nature-driven agricultural solutions, reinforcing India’s position as a leader in global agri-tech innovation.
As part of the agreement, C-CAMP has exclusively transferred two groundbreaking biocontrol technologies, AphidControl and XanthoControl, to PI. These eco-friendly solutions offer an innovative approach to pest and disease management, reducing dependence on traditional chemical pesticides.
This partnership aligns with PI’s broader vision of expanding its presence in the biological solutions sector. Over the past two years, the company’s biological product segment has witnessed a robust 45% revenue growth. The addition of C-CAMP’s cutting-edge technologies further strengthens PI’s integrated approach to sustainable agriculture.
Mayank Singhal, Vice Chairman and Managing Director, PI Industries Ltd, said, “As the world confronts the dual challenges of climate change and food security, biological solutions have transitioned from being an option to a necessity. Through our collaboration with C-CAMP, we are leveraging cutting-edge science to develop sustainable, nature-driven solutions that not only mitigate immediate agricultural threats but also pave the way for a more resilient and eco-friendly farming ecosystem. This partnership reinforces our commitment to innovation and sustainability while taking India’s scientific prowess to the global stage.”
On February 24, 2025, PI Industries share price opened at ₹1,158.00, up from its previous close of ₹1,131.85. At 10:16 AM, the share price of PI Industries was trading at ₹1,183.65, up by 4.58% on the NSE.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Feb 24, 2025, 2:14 PM IST
Nikitha Devi
Nikitha is a content creator with 6+ years of experience in the financial domain. Specialising in personal finance, investments, and market insights, Nikitha simplifies complex financial topics, making them accessible to readers.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates